Clincosm LogoSign in Get a demo

Using Behavioral Science to Improve Colorectal Cancer Screening Rates With Mailed FIT Kits

Sponsor
University of California, Los Angeles (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04746469
Collaborator
(none)
2,500
Enrollment
1
Location
2
Arms
17.9
Anticipated Duration (Months)
139.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

As a part of UCLA Health's continued goal of improving patient care the investigators are updating our mailing campaign for our FIT Kit colorectal cancer screening that the investigators administer 2 times per year to include an automated phone call reminder to patients who are overdue for average-risk colorectal cancer screening and enrolled in a mailed FIT program. This will help the investigators evaluate if automated phone calls are effective at improving compliance with CRC screening, in addition to mailed FIT and embedded electronic health record (EHR) portal messages to patients.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Delayed automated phone call
 N/A

Detailed Description

UCLA Health has a biannual mailed FIT program designed to capture patients overdue for CRC screening who are average-risk for CRC. With every campaign, the investigators attempt to improve the return rates for patients receiving the FIT Kits. For the current campaign, all patients enrolled will receive usual care and the investigators are delivering an automated phone call to half the eligible patients reminding them to return their FIT kits and prompting them to request a new kit if needed. The investigators will investigate if this intervention increases the number of patients who complete the mailed Fit Kit or any type of CRC screening over a 6-month follow up period. This quality improvement project will help the investigators improve the processes of care for the patients, and community. If this phone call is successful the investigators will likely expand it to the entire population in future FIT Kit mailer campaigns. However, if it is not effective this will help the investigators minimize the number of calls/interventions the investigators send to patients and will hopefully allow for more useful outreach to patients in the future.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
2500 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
~2500 patients who are overdue for average-risk CRC screening and are enrolled in UCLA Health biannual mailed FIT program will be randomized to either control (mailed FIT kit + standard messaging) or intervention (mailed FIT Kit + standard messaging + delayed automated phone reminder)~2500 patients who are overdue for average-risk CRC screening and are enrolled in UCLA Health biannual mailed FIT program will be randomized to either control (mailed FIT kit + standard messaging) or intervention (mailed FIT Kit + standard messaging + delayed automated phone reminder)
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Impact of Automated Telephone Outreach on Colorectal Cancer Screening Uptake Among Patients Who Receive Mailed Fecal Immunochemical Tests (FIT)
Actual Study Start Date :
Sep 2, 2020
Anticipated Primary Completion Date :
Mar 1, 2022
Anticipated Study Completion Date :
Mar 1, 2022

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

This group will receive standard FIT mailer protocol (includes mailed FIT kit plus standardized messaging via EHR portal)
Experimental: Intervention

This group will receive standard FIT mailer protocol (as above) PLUS delayed automated phone reminder

Behavioral: Delayed automated phone call
Cipher provides automated phone calls to patients; in this case the script for Cipher was modified to provide patients a reminder to return FIT kits, allow patients to request a new kit in case they need a replacement, and to allow patients to provide information if they already completed CRC screening
Other Names:
  • Cipher phone reminder

    		•

    Outcome Measures

    Primary Outcome Measures

    1. Overall colorectal cancer screening uptake (any modality) [6 months]

      Rate of completion of CRC screening by any of the following: FIT, colonoscopy, CT colonography, sigmoidoscopy or FIT-DNA within study period.

    Secondary Outcome Measures

    1. Colorectal cancer screening uptake by modality [6 months]

      Rate of completion of CRC screening by modality type

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • Overdue for average-risk colorectal cancer screening

    • Active primary care provider at UCLA seen within last 3 years

    Exclusion Criteria:

    • Inactive mychart status at time of enrollment

    • Died within follow-up period

    • Received FIT kit in prior 6 months

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UCLA Health Department of Medicine, Quality Office Los Angeles California United States 90095

    Sponsors and Collaborators

    • University of California, Los Angeles

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Daniel M. Croymans, MD, MBA, MS, Principal Investigator, University of California, Los Angeles
    ClinicalTrials.gov Identifier:
    NCT04746469
    Other Study ID Numbers:
    • IRB #19-001418
    First Posted:
    Feb 9, 2021
    Last Update Posted:
    Apr 28, 2021
    Last Verified:
    Apr 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Colorectal Neoplasms

    Study Results

    No Results Posted as of Apr 28, 2021